RESMED INC
RMDNYSE🏆 #414 by market capEarnings Oct 22US Equity
$222.57▲ $0.47 (+0.21%)
LiveTrack RMD
Get earnings, price moves & breaking news on Telegram
24h▲ 0.2%
7d▲ 0.3%
14d▼ 3.0%
30d▼ 7.4%
ytd▼ 7.6%
1y▼ 17.9%
🏦Market Cap
$32.29B
Mid Cap
📈Revenue Growth (YoY)
+9.8%
Slowing
📊Gross Margin
61.1%
High
💵FCF Margin
28.8%
Strong
⚖️P/S Ratio
5.7x
Fair
Otter Score
72
Fair
RESMED INC
RMDAnalyst Ratings
Price
$222.57
Total
35
Raised
6
Lowered
11
Avg PT
$242.70
H / L
$300 / $213
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
RBC Capital | Upgraded | Sector Perform → Outperform | 2026-09-15 | $262.00 | +17.70% |
Keybanc | Reiterated | Overweight | 2026-08-31 | $267.00 | +20.00% |
Wells Fargo | Reiterated | Equal Weight | 2026-08-07 | $225.00 | +1.10% |
Piper Sandler | Reiterated | Neutral | 2026-08-07 | $275.00 | +23.60% |
Mizuho | Reiterated | Outperform | 2026-07-15 | — | — |
Citigroup | Downgraded | Buy → Neutral | 2026-07-13 | — | — |
Jefferies | Reiterated | Hold | 2026-07-10 | $225.00 | +1.10% |
Morgan Stanley | Downgraded | Overweight → Equal Weight | 2026-06-17 | $230.00 | +3.30% |
Stifel | Reiterated | Hold | 2026-01-30 | — | — |
Baird | Downgraded | Outperform → Neutral | 2025-12-16 | — | — |
UBS | Reiterated | Buy | 2025-08-01 | $300.00 | +34.80% |
JP Morgan | Reiterated | Overweight | 2025-04-24 | — | — |
Needham | Reiterated | Hold | 2025-01-31 | $180.00 | −19.10% |
B of A Securities | Reiterated | Buy | 2024-09-26 | — | — |
Wolfe Research | Downgraded | Peer Perform → Underperform | 2024-09-18 | $180.00 | −19.10% |
Oppenheimer | Downgraded | Outperform → Perform | 2024-06-25 | $175.00 | −21.40% |
CLSA | Reiterated | Outperform → Buy | 2022-01-13 | — | — |
Macquarie | Upgraded | Neutral → Outperform | 2021-12-06 | — | — |
KeyBanc | Reiterated | Sector Weight → Equal Weight | 2019-11-22 | $267.00 | +20.00% |
Goldman Sachs | Upgraded | Neutral → Buy | 2019-07-29 | — | — |
Deutsche Bank | Upgraded | Hold → Buy | 2019-03-20 | — | — |
BMO Capital | Upgraded | Market Perform → Outperform | 2018-12-10 | — | — |
Barclays | Reiterated | Underweight | 2017-10-27 | — | — |
Bank of America | Downgraded | Buy → Neutral | 2017-08-02 | — | — |
Credit Suisse | Downgraded | Outperform → Neutral | 2017-08-02 | — | — |
PiperJaffray | Downgraded | Overweight → Neutral | 2016-04-27 | — | — |
BBY | Reiterated | Underperform | 2015-02-02 | — | — |
Northland Securities | Downgraded | Market Perform → Underperform | 2014-05-27 | — | — |
Northland Capital Markets | Downgraded | Market Perform → Underperform | 2014-05-27 | — | — |
William Blair | Downgraded | Outperform → Market Perform | 2014-01-24 | — | — |
Shaw Stockbroking | Reiterated | Buy | 2013-09-20 | — | — |
S&P Capital IQ | Reiterated | Buy | 2013-02-26 | — | — |
CBA | Upgraded | Hold → Buy | 2012-08-07 | — | — |
Feltl & Co. | Reiterated | Hold | 2012-08-06 | — | — |
Bank oferica | Reiterated | Neutral | 2012-04-27 | — | — |
Institution
RBC Capital
Upgraded · Sector Perform → Outperform · 2026-09-15
$262.00
+17.70%
Keybanc
Reiterated · Overweight · 2026-08-31
$267.00
+20.00%
Wells Fargo
Reiterated · Equal Weight · 2026-08-07
$225.00
+1.10%
Piper Sandler
Reiterated · Neutral · 2026-08-07
$275.00
+23.60%
Mizuho
Reiterated · Outperform · 2026-07-15
—
—
Citigroup
Downgraded · Buy → Neutral · 2026-07-13
—
—
Jefferies
Reiterated · Hold · 2026-07-10
$225.00
+1.10%
Morgan Stanley
Downgraded · Overweight → Equal Weight · 2026-06-17
$230.00
+3.30%
Stifel
Reiterated · Hold · 2026-01-30
—
—
Baird
Downgraded · Outperform → Neutral · 2025-12-16
—
—
UBS
Reiterated · Buy · 2025-08-01
$300.00
+34.80%
JP Morgan
Reiterated · Overweight · 2025-04-24
—
—
Needham
Reiterated · Hold · 2025-01-31
$180.00
−19.10%
B of A Securities
Reiterated · Buy · 2024-09-26
—
—
Wolfe Research
Downgraded · Peer Perform → Underperform · 2024-09-18
$180.00
−19.10%
Oppenheimer
Downgraded · Outperform → Perform · 2024-06-25
$175.00
−21.40%
CLSA
Reiterated · Outperform → Buy · 2022-01-13
—
—
Macquarie
Upgraded · Neutral → Outperform · 2021-12-06
—
—
KeyBanc
Reiterated · Sector Weight → Equal Weight · 2019-11-22
$267.00
+20.00%
Goldman Sachs
Upgraded · Neutral → Buy · 2019-07-29
—
—
Deutsche Bank
Upgraded · Hold → Buy · 2019-03-20
—
—
BMO Capital
Upgraded · Market Perform → Outperform · 2018-12-10
—
—
Barclays
Reiterated · Underweight · 2017-10-27
—
—
Bank of America
Downgraded · Buy → Neutral · 2017-08-02
—
—
Credit Suisse
Downgraded · Outperform → Neutral · 2017-08-02
—
—
PiperJaffray
Downgraded · Overweight → Neutral · 2016-04-27
—
—
BBY
Reiterated · Underperform · 2015-02-02
—
—
Northland Securities
Downgraded · Market Perform → Underperform · 2014-05-27
—
—
Northland Capital Markets
Downgraded · Market Perform → Underperform · 2014-05-27
—
—
William Blair
Downgraded · Outperform → Market Perform · 2014-01-24
—
—
Shaw Stockbroking
Reiterated · Buy · 2013-09-20
—
—
S&P Capital IQ
Reiterated · Buy · 2013-02-26
—
—
CBA
Upgraded · Hold → Buy · 2012-08-07
—
—
Feltl & Co.
Reiterated · Hold · 2012-08-06
—
—
Bank oferica
Reiterated · Neutral · 2012-04-27
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space